Treeline | Blog
Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. We do not use cookies of this type. Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. We do not use cookies of this type. We do not use cookies of this type.
Treeline | Blog Mandate Method Medicines Team News Back 9.3.2025 Medicines in the making: introducing our first clinical programs By Josh Bilenker, M.D., Co-Founder and CEO, Treeline Treeline was founded with an ambitious vision – to create the next great enduring biopharma by pursuing carefully selected targets with the best available technology. That meant taking on the challenge of building an integrated team across disciplines—lab based and computational—working together, under the same roof. It also meant building a deep preclinical pipeline with flexibility to vet projects thoroughly bef
saved by
related reading
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Tech vs Biotech - Celine Haliouacelinehh.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Curie.Biocurie.bio
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- Letter | Terrainterrain.com
- Multiply Labs | Robotic Biomanufacturing Infrastructuremultiplylabs.com
- Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
- Medicine's Endgamenotboring.co
- Network Bio Q1 2023 Investor Update - by network.bionetworkbio.substack.com
- About – Medramedra.ai
- How Linear builds product - by Lenny Rachitskylennysnewsletter.com